ITGAM and neoplasm: Nevertheless, M1 coinjection inhibited tumor weight and affected myeloid and lymphoid cell subsets by inhibiting CD11b+ cell infiltration and decreasing the number of T-regs in the TME (Figure 5), demonstrating the therapeutic potential of the M1 polarization strategy by vdIFNg.